Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Jul;60(1):107-108.
doi: 10.1111/apt.18067. Epub 2024 May 27.

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply

Lukas Burghart  1   2 , Benedikt Silvester Hofer  2   3   4 , Emina Halilbasic  2   3 , Benedikt Simbrunner  2   3   4 , Albert Friedrich Staettermayer  2   3   4 , Michael Trauner  2   3 , Thomas Reiberger  2   3   4
Affiliations
Comment

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply

Lukas Burghart et al. Aliment Pharmacol Ther. 2024 Jul.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Ao X, Zeng Y, Wang X, Fan X. Letter: fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis. Aliment Pharmacol Ther. 2024;60:105–106.
    1. Lammers WJ, van Buuren HR, Hirschfield GM, Janssen HL, Invernizzi P, Mason AL, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow‐up study. Gastroenterology. 2014;147(6):1338–1349.e5.
    1. Tanaka A, Hirohara J, Nakano T, Matsumoto K, Chazouillères O, Takikawa H, et al. Association of bezafibrate with transplant‐free survival in patients with primary biliary cholangitis. J Hepatol. 2021;75:565–571.
    1. Hofer BS, Burghart L, Halilbasic E, Simbrunner B, Petrenko O, Mandorfer M, et al. Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Aliment Pharmacol Ther. 2024;59:962–972.

MeSH terms

LinkOut - more resources